S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:HSTO

Histogen Stock Forecast, Price & News

$1.02
+0.06 (+6.25 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.92
Now: $1.02
$1.07
50-Day Range
$0.76
MA: $1.13
$1.62
52-Week Range
$0.75
Now: $1.02
$7.50
Volume5.68 million shs
Average Volume2.55 million shs
Market Capitalization$12.76 million
P/E RatioN/A
Dividend YieldN/A
Beta1.37
Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.

MarketRank

Overall MarketRank

0.46 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HSTO
CUSIPN/A
CIKN/A
Phone858 526 3100
Employees22

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.72 million
Book Value$6.09 per share

Profitability

Net Income$-11,390,000.00

Miscellaneous

Market Cap$12.76 million
Next Earnings Date3/10/2021 (Estimated)
OptionableNot Optionable
$1.02
+0.06 (+6.25 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HSTO News and Ratings via Email

Sign-up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Histogen (NASDAQ:HSTO) Frequently Asked Questions

What stocks does MarketBeat like better than Histogen?

Wall Street analysts have given Histogen a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Histogen wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Histogen's next earnings date?

Histogen is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for Histogen
.

How were Histogen's earnings last quarter?

Histogen Inc. (NASDAQ:HSTO) released its quarterly earnings data on Tuesday, November, 10th. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.80) by $0.53. The business earned $0.50 million during the quarter.
View Histogen's earnings history
.

Who are some of Histogen's key competitors?

What other stocks do shareholders of Histogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Histogen investors own include Carnival Co. & (CCL), Intel (INTC), Genius Brands International (GNUS), Gilead Sciences (GILD), Clovis Oncology (CLVS), B2Gold (BTG), BIOLASE (BIOL), (BBI.V) (BBI), Advanced Micro Devices (AMD) and Akers Biosciences (AKER).

Who are Histogen's key executives?

Histogen's management team includes the following people:
  • Mr. Richard W. Pascoe, CEO, Pres & Director (Age 56)
  • Dr. Gail K. Naughton, Founder, Chief Scientific Officer & Chief Bus. Officer (Age 64)
  • Ms. Susan A. Knudson, Exec. VP & CFO (Age 56)
  • Dr. Martin Latterich, VP of Technical Operations (Age 53)
  • Ms. Eileen Naughton Brandt, Director of Corp. Communications
  • Mr. Stephen Hill Jr., VP & Controller
  • Ms. Moya M. Daniels, Exec. VP and Head of Regulatory, Quality & Clinical Operations
  • Mr. Thomas L. Hubka, Director of Bus. Operations & Corp. Sec. (Age 33)

What is Histogen's stock symbol?

Histogen trades on the NASDAQ under the ticker symbol "HSTO."

How do I buy shares of Histogen?

Shares of HSTO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Histogen's stock price today?

One share of HSTO stock can currently be purchased for approximately $1.02.

How big of a company is Histogen?

Histogen has a market capitalization of $12.76 million and generates $21.72 million in revenue each year. Histogen employs 22 workers across the globe.

What is Histogen's official website?

The official website for Histogen is www.histogen.com.

How can I contact Histogen?

Histogen's mailing address is 16745 W. Bernardo Dr. Suite 250, San Diego CA, 92127. The company can be reached via phone at 858 526 3100 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.